IQVIA RWE Expert Discusses Trust, COVID-19, and FDA Framework

October 25, 2021

IQVIA’s Chirag Ghai recently shared his thoughts on real world evidence (RWE), its use in addressing brought by the COVID-19 pandemic, and the importance of trust. He also calls for increased standardization among real world data (RWD) sources.

Ghai remarks, “Later this year, I expect the industry will receive further clarity and assistance with acceptance of RWE in rare diseases driven by ethical reasons. It will clarify what types of data sources to use for label expansions. Additionally, for certain types of studies, guidelines should highlight that the relevant endpoints and surrogate endpoints are acceptable for regulatory grade evidence.” Read more here.

(Source: Chirag Ghai, The Evidence Base, 10/15/21)

Share This Story!